IHI ETF Analysis: U.S. Medical Devices | NYSE
Health | NYSE, USA | Market Cap: 3.080m USD | 12M Return: -18.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 160M
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that seeks to track the performance of the Dow Jones U.S. Select Medical Equipment Index, a benchmark measuring the U.S. medical equipment sector as defined by S&P Dow Jones Indices LLC. The underlying index is composed of companies that manufacture or distribute medical devices such as MRI scanners, prosthetics, pacemakers, and X-ray machines, focusing on non-disposable, durable equipment rather than consumables.
The fund is structured as a non-diversified ETF, meaning it may hold a more concentrated position in a smaller number of issuers compared to diversified funds. Listed on the NYSE since its 2006 IPO, IHI provides investors targeted exposure to a segment of the healthcare industry typically driven by hospital capital spending, demographic aging trends, and innovation in diagnostic and therapeutic technologies. The medical device sector is generally characterized by high research and development costs and a regulatory environment overseen by the U.S. Food and Drug Administration (FDA), which influences product approval timelines and market entry.
- Hospital capital spending recovers as elective procedures rebound
- FDA approval pipeline accelerates medical device innovation
- Aging population boosts demand for implants and imaging devices
As of July 24, 2026, the stock is trading at USD 49.44 with a total of 2,419,733 shares traded. Over the past week, the price has changed by -5.29%, over one month by +0.65%, over three months by -6.59% and over the past year by -18.77%.
Current recommended Stop Loss: 47.80 (which is 3.3% or 1.4 ATR below the current price).
U.S. Medical Devices has no consensus analysts rating.